Thomas B. Cueni

Director General

Usman Azam

Global Head of the Cell and Gene Therapies Unit, Novartis Pharmaceuticals

Stephen Cook

VP Vaccine Global Regulatory Affairs, Head of International Region, GlaxoSmithKline

Luciano Rosetti

Head of Global Research and Development, Merck Serono

Gerry Elsdon

Media Personality, International TB Ambassador & Humanitarian

Cyntia Genolet

Manager, Regulatory and Health Policy

Thomas Zeltner, Thomas Cueni & Konji Sebati Thomas Zeltner, Thomas Cueni & Konji Sebati

Swiss Academies of Arts and Sciences, DG, IFPMA & CEO, IPASA

David Neal

Head of Policy, Polygeia

Rhys Wenlock

Medical Student, Downing College

Abigail Wood

Researcher, Polygeia

Dakshina Reddy

Regulatory Expert

Marc Gentilini

General Delegate, Fondation Chirac

Paul Dearden

Director, Regulatory Policy & Intelligence, AbbVie

Caroline Mendy

Senior Manager, Regulatory Policy, IFPMA

Estelle Michael

Senior Regulatory Policy Director, AstraZeneca

Dr Konji Sebati

Dr Konji Sebati is IPASA CEO & Mr Eduardo Pisani is IFPMA Director General

Abraham Palache

Influenza Expert

Gino Gramp

R&D Policy Director (Amgen) & IFPMA Biotherapeutics Group Chair

Soeren Mattke

Health Policy Expert

Paul Stoffels

Executive Vice President, Chief Ccientific Officer Johnson & Johnson

Mario Ottiglio

Director, Public Affairs, Communications and Global Health Policy, IFPMA

Guilherme Cintra

Senior Manager, Innovation, Intellectual Property and Trade

Pierre Van Damme

Professor, Faculty of Medicine and Health Sciences, Antwerp University

John Kalland

Senior Vice President, Director of Manufacturer Relations and Services, Walgreens Boots Alliance

Andrew Jenner

Indpendent Consultant

Matthew Downham, PHD

Associate Director, AstraZeneca/MedImmune (Liverpool, UK)

Cary Adams

Chief Executive Officer, Union for International Cancer Control

Thomas Cueni & Paola Barbarino Thomas Cueni & Paola Barbarino

DG of IFPMA & CEO of Alzheimer’s Disease International

Denis Lacombe

Director Headquarters, EORTC

Emilio Emini

Senior Vice President of Vaccine Research and Development, Pfizer Inc.

Ruth March

VP and Head of Personalised Healthcare and Biomarkers, AstraZeneca

Antke Post

Medical Fellow in Neuroscience Discovery and Clinical Investigation, Eli Lilly and Company

Ronald Piervincenzi

Chief Executive Officer, United States Pharmacopeial Convention (USP)